On 6 Nov 2026, Dhanvantri Jeevan Rekha was priced at ₹20.85, or 17.0× trailing earnings, against an industry P/E of 47.7×, and the shares are 30% below their 52-week high. Its ROCE of 1.3% is the lowest among the 7 largest Medical Care Facilities peers, and sales grew 13% a year over 3 years. It is a small-cap company with a market cap of ₹8.55 Cr, ranked 39th of 40 Medical Care Facilities companies by market cap; the shares fell 26% over the past year.
- ₹20.85
- ₹20.85
- ₹20.85
- ₹19.86
- 193
Health check
- ReturnsBehind
−26.4% over a year, better than 0 of 7 peers.
- Price tagCheaper
P/E 17.0 vs industry 47.7.
- GrowthSlow
Sales +13.5% a year over 3 years.
- ProfitabilityWeak
ROCE 1.3% vs peer median 11.9%.
- Balance sheetFair
Piotroski 4 of 9.
- Red flags2 to check
Return on equity is low at 3.8%.
Small cap
Market sensitivity
Key metrics
- Market cap
- ₹8.55 Cr
- Small cap
- P/E
- 17.0
- Industry 47.7
- Price to book
- 0.94
- Peers 8.03
- Dividend yield
- 0.00%
- ROE
- 3.8%
- Peers 12.8%
- ROCE
- 1.3%
- Peers 11.9%
- Debt to equity
- n/a
- Debt ₹0.00 Cr
- EPS (TTM)
- ₹1.23
- OPM (TTM)
- 3.3%
- Net margin 1.8%
- Sales growth
- +41.6%
- Latest quarter vs a year ago
- Profit growth
- +200.0%
- Latest quarter vs a year ago
- Price to sales
- 0.30
- EV/EBITDA 3.9
Strengths and risks
Strengths
- Quarterly profit up 200.0% on a year ago.
- Quarterly sales up 41.6% on a year ago.
- P/E of 17.0 against an industry P/E of 47.7.
Risks to check
- Return on equity is low at 3.8%.
- 30% below its 52-week high.
About Dhanvantri Jeevan Rekha
Dhanvantri Jeevan Rekha Limited engages in the provision of healthcare and hospital services in India. It offers medical, diagnostic and therapeutic services. The company also provides specialty services, such as cardiology, gastroenterology, gastro surgery, neurology, urology, neuro surgery, orthopaedic surgery, nephrology, oral and maxillofaccial surgery, pathology, otorhinolarygology, internal medicine, pulmonology, and other diagnostic services, as…
- Headquarters
- Meerut
- Employees
- 118
- Sector
- Healthcare
- ISIN
- INE239F01015
- Website
- dhanvantrihospital.in
Price range
- Avg volume (3M)
- 669
- 1-year return
- minus 26.4%
- From 52-week high
- minus 30.5%
Peers · Medical Care Facilities
| Company | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| APOLLOHOSPApollo Hospitals Enterprise | 8,446.00 | plus 0.90% | 1,21,441 | 54.0 | 11.45 | 19.2% | 22.5% | 15.1% | 14.8% | 33.3% | 0.24% | plus 7.2% |
| MAXHEALTHMax Healthcare Institute | 934.00 | plus 0.21% | 90,909 | 66.1 | 8.03 | 12.6% | 12.8% | 26.8% | 22.4% | 9.3% | 0.21% | minus 18.1% |
| MANIPALHOSManipal Health Enterprises | 646.70 | minus 1.61% | 85,065 | 133.6 | 9.05 | 9.8% | 9.2% | 17.8% | – | – | 0.00% | minus 1.5% |
| ASTERDMAster DM Quality Care | 713.15 | minus 0.89% | 62,092 | 115.6 | 8.03 | 9.4% | 9.7% | 19.2% | 15.7% | −3.0% | 0.42% | plus 4.5% |
| FORTISFortis Healthcare | 766.90 | minus 6.45% | 57,898 | 55.3 | 5.52 | 11.9% | 11.1% | 22.4% | 13.3% | 20.9% | 0.12% | minus 19.6% |
| NHNarayana Hrudayalaya | 1,903.00 | minus 0.65% | 38,650 | 44.7 | 7.73 | 11.4% | 19.1% | 18.5% | 20.5% | 9.9% | 0.23% | plus 4.7% |
| MEDANTAGlobal Health | 1,387.60 | minus 0.15% | 37,264 | 60.4 | 8.63 | 15.0% | 15.2% | 20.9% | 17.2% | 19.5% | 0.04% | plus 11.2% |
| ZDHJERKDhanvantri Jeevan Rekha | 20.85 | plus 4.98% | 9 | 17.0 | 0.94 | 1.3% | 3.8% | 3.3% | 13.5% | – | 0.00% | minus 26.4% |
| Median of 7 peers | – | −0.65% | 62,092 | 60.4 | 8.03 | 11.9% | 12.8% | 19.2% | 16.5% | 14.7% | 0.21% | 4.5% |
Quarterly results
| ₹ Cr | Jun 25 | Sep 25 | Dec 25 | Mar 26 | Jun 26 |
|---|---|---|---|---|---|
| 5.5 | 5.8 | 7.3 | 7.2 | 7.8 | |
| 5.4 | 5.9 | 7 | 6.9 | 7.5 | |
| 0.1 | −0.1 | 0.3 | 0.4 | 0.3 | |
| 2.5% | −1.0% | 4.1% | 5.4% | 4.0% | |
| 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |
| – | – | 0 | – | 0 | |
| 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | |
| 0.1 | −0.1 | 0.2 | 0.3 | 0.2 | |
| 0.1 | −0.1 | 0.2 | 0.3 | 0.2 | |
| 0.15 | -0.34 | 0.41 | 0.72 | 0.44 |
Profit & loss
- Sales CAGR 3Y
- +13.5%
- ROE
- 3.8%
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 17.7 | 20.5 | 22.7 | 25.9 | |
| – | +15.7% | +10.7% | +14.2% | |
| 17.1 | 19.6 | 21.9 | 25 | |
| 0.6 | 0.8 | 0.7 | 0.8 | |
| 3.3% | 4.1% | 3.3% | 3.3% | |
| 0.2 | 0.3 | 0.4 | 0.3 | |
| – | 0 | – | 0 | |
| 1 | 0.9 | 0.6 | 0.7 | |
| – | – | −0 | −0.1 | |
| −0.1 | 0.3 | 0.6 | 0.4 | |
| −50.0% | 35.3% | 8.9% | 2.3% | |
| −0.2 | 0.2 | 0.5 | 0.4 | |
| – | – | +206.3% | minus 22.8% | |
| -0.53 | 0.40 | 1.60 | 0.94 |
Forecast
Balance sheet
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 4.2 | 4.2 | 4.2 | 4.2 | |
| 5.2 | 5.3 | 6 | 6.4 | |
| 4.5 | 5.5 | 4.6 | 7.1 | |
| 13.8 | 15 | 14.8 | 17.6 | |
| 8.5 | 8.1 | 8.4 | 8.6 | |
| 0.8 | 0.3 | 0.6 | 1 | |
| 0.9 | 3.5 | 2.5 | 3.5 | |
| 3.6 | 3.1 | 3.2 | 4.5 | |
| 13.8 | 15 | 14.8 | 17.6 |
Cash flow
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| −0.4 | 3 | −0.2 | 1.8 | |
| −0.6 | −0.4 | −0.7 | −0.7 | |
| −1 | 2.6 | −0.9 | 1.1 | |
| −0.6 | −0.5 | −0.8 | −0.8 | |
| −1 | 2.6 | −1.1 | 1 |
Shareholding pattern
This company is listed only on BSE, so there’s no NSE category split. See Major shareholders below for the named holders.
Major shareholders
Filings & events
News
No recent news coverage found.